Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Discover which indices swing the most and how those swings translate into trading opportunities, with practical tips to gauge momentum.
24,519 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Chasing Nvidia’s AI-driven rally is tempting, but utility stocks offer stable dividends, growth through grid moderniz...
City leaders push incremental reforms alongside a revived mega-plan for Sunnyside Yard, arguing patience is key in a ...
If you’re building a simple, durable plan, understanding three core ideas around VOO can save you money and stress. T...
A big trade in a technology-focused ETF last quarter offers more than a headline. This article digs into what investo...
Target's Circle Deal Days is more than a promo. It could be a lever for traffic, online sales, and margins. This arti...
Salesforce has long been a growth leader in cloud software, but recent performance has cooled. This guide dives into ...
Magnolia (MGY) is delivering a pivotal Q1 2026 performance that tests the durability of its business model. This arti...
The S&P 500 surged to a new high driven by a small group of mega-cap tech giants, even as hundreds of other component...
A Taboola director disclosed a sizable open-market sale of 61,000 shares. This article explains what insider trades c...
Tim Cook's travels to China are more than diplomacy. This piece outlines how what cook's trip china could mean for Ap...
The news that Innodata’s founder sold a large chunk of shares is sending ripples through the market. This article bre...